Biochemists discover how reactive oxygen species affect cisplatin resistance in ovarian cancer cells

September 13, 2018, RUDN University
The mechanism of oxidative stress. Credit: RUDN University

A team of sciences from the RUDN Institute of Medicine has reported how reactive oxygen species (ROSs) affect the resistance of ovarian cancer cells to chemotherapy on the example of cisplatin—an antitumor drug used to treat this type of malignant growth. Practical application of the research results would help improve medical treatment schemes for cancer patients. The article was published in the Materials of FEBS Congress.

Long-term use of anti- drugs may lead to the development of , reducing the efficiency of chemotherapy. Scientists are aware of several mechanisms for drug resistance development in tumor cells. They are to a large extent associated with the activation of proteins that get medicinal drugs out of cells, as well as with changes in the genes controlling cell survival and programmed cell death (apoptosis). One of the least studied mechanisms of drug resistance development is connected with the influence of ROSs in cells that can destroy organic molecules.

RUDN biochemists studied the mechanism of drug resistance development in ovarian cancer cells under treatment with cisplatin. The researchers found that the process was connected with increased expression of genes of key antioxidant enzymes: Mn-superoxide dismutase, catalase, glutathione peroxidase-1, hemoxygenase-1, as well as reduced expression of the enzyme NADPH-oxidase, which is responsible for ROS generation in the cell.

In the normal state, there is a balance between the formation and destruction of ROSs. Any changes in this balance may cause damage in the internal structure of the cells, leading to number of diseases, including cancer. On the other hand, high concentrations of ROSs may also lead to the death of cancer cells. This effect is used in cancer therapy, and cisplatin may operate on a similar principle.

In their work, the scientists used the real-time RT-PCR method and western blotting to evaluate gene expression. The discovered that the redox-dependent mechanism of drug resistance development shows how well tumor cells can adapt to negative environmental conditions. The mechanism helps healthy survive, but hinders the treatment of malignant tumors.

"We found that under treatment of the with cisplatin, a new mechanism is triggered, changing the balance between generation and elimination of ROSs; it is called the adaptive antioxidant response. The mechanism of drug resistance development would help create new combined methods for ovarian cancer treatment," said Elena Kalinina, the author of the study, doctor of biological science, and professor of RUDN Institute of Medicine.

Explore further: Researchers study the cancer cell genes that resist drugs

More information: Materials of FEBS Congress, DOI: 10.1002/2211-5463.12453

Related Stories

Researchers study the cancer cell genes that resist drugs

September 25, 2017

Researchers from the People's Friendship University of Russia (RUDN University) have studied the mechanism of drug resistance for ovarian and breast cancer cells. They discovered that these cancer cells have a redox-dependent ...

Understanding drug resistance in ovarian cancer

August 24, 2018

Work just published in Cancer Research by Drs. Hugo Wurtele and Elliot Drobetsky (Maisonneuve-Rosemont Hospital Research Center- CIUSSS de l'Est-de-l'Île-de-Montréal and Université de Montréal) sheds new light on the ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018

Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

Combination therapy improved chemoresistance in ovarian cancer

November 1, 2016

Treating ovarian cancer with platinum-based chemotherapy drugs such as cisplatin is initially very effective, with about four out of five patients responding favorably. However, most of these patients quickly become resistant ...

Recommended for you

Field-responsive mechanical metamaterials (FRMMs)

December 11, 2018

In a recent study published in Science Advances, materials scientists Julie A. Jackson and colleagues presented a new class of materials architecture called field-responsive mechanical metamaterials (FRMM). The FRMMs exhibit ...

Researchers develop smartphone-based ovulation test

December 11, 2018

Investigators from Brigham and Women's Hospital are developing an automated, low-cost tool to predict a woman's ovulation and aid in family planning. Capitalizing on advancements in several areas, including microfluidics, ...

CRISPR method for conditional gene regulation

December 11, 2018

A team of engineers at the University of Delaware has developed a method to use CRISPR/Cas9 technology to set off a cascade of activities in cells, a phenomenon known as conditional gene regulation. Their method, described ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.